Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status

Chondrosarcomas are chemo- and radiotherapy resistant and frequently harbor mutations in isocitrate dehydrogenase (IDH1 or IDH2), causing increased levels of D-2-hydroxyglutarate (D-2-HG). DNA repair defects and synthetic lethality with poly(ADP-ribose) polymerase (PARP) inhibition occur in IDH muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Venneker, Sanne, Kruisselbrink, Alwine B., Briaire-de Bruijn, Inge H., de Jong, Yvonne, van Wijnen, Andre J., Danen, Erik H.J., Bovée, Judith V.M.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966531/
https://www.ncbi.nlm.nih.gov/pubmed/31810230
http://dx.doi.org/10.3390/cancers11121918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966531/
https://www.ncbi.nlm.nih.gov/pubmed/31810230
http://dx.doi.org/10.3390/cancers11121918

Ejemplares similares